Kouki Harasaki
Gründer bei Hanwha Impact Partners, Inc.
Profil
Kouki Harasaki is the Founding / Managing Partner at Bioluminescence Ventures.
Dr. Harasaki has over 25 years of biomedical science experience working across major health systems, research institutes, biopharmaceutical corporations, technology companies, and venture capital firms.
He has led over $600M in financing deals that have funded over 25 therapeutics programs across stages (discovery to marketed), across therapeutic areas (Cardiovascular & Metabolism, Immunology, Oncology, Neuro/CNS), and across modalities (small molecules, biologics, genome editing platforms, cell therapies).
Prior to founding Bioluminescence Ventures, he was a Managing Director at M12 / Microsoft Ventures, where he led Life Science investments and helped develop Microsoft Life Science corporate strategy.
Prior to M12, Dr. Harasaki was a senior Partner at Andreessen Horowitz, where he managed four Bio Fund Partners and worked across the portfolio of 25+ Bio Fund companies.
PhD, Clinical Biochemistry, University of Cambridge (Wellcome Trust Fellow)
MBA, Harvard Business School (Robert S.
Kaplan Fellow)
BA, Molecular & Cellular Biology, Cornell University
Aktive Positionen von Kouki Harasaki
| Unternehmen | Position | Beginn |
|---|---|---|
Artificial, Inc.
 Artificial, Inc. Packaged SoftwareTechnology Services Artificial, Inc. engages in the development of software to close the loop between humans and robots in the lab. It offers flow scheduler, elements SDK, flow tools, and substrate core. The company is headquartered in Palo Alto, CA. | Direktor/Vorstandsmitglied | 01.01.2021 |
Huue, Inc.
 Huue, Inc. BiotechnologyHealth Technology Huue, Inc. develops biotechnology to provide indigo dyeing solutions to the textile and fashion industry. The company was founded by Michelle Zhu and Tammy Hsu in 2018 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.01.2022 |
Code Ocean, Inc.
 Code Ocean, Inc. Packaged SoftwareTechnology Services Code Ocean, Inc. operates as a cloud-based computational reproducibility platform. It provides researchers and developers to share, discover and run code published in academic journals and conferences. The company was founded by Simon Adar in 2015 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.04.2022 |
Hanwha Impact Partners, Inc.
 Hanwha Impact Partners, Inc. Investment ManagersFinance Hanwha Impact Partners Inc (Hanwha Impact Partners) is a venture capital firm founded in 2022 by Kouki Harasaki. The firm is headquartered in San Francisco, California. | Gründer | - |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kouki Harasaki
| Unternehmen | Position | Ende |
|---|---|---|
M12 Ventures
 M12 Ventures Investment ManagersFinance M12 Ventures (M12) is a venture capital subsidiary of Microsoft Corp. founded in 2016. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.01.2022 |
AH Capital Management LLC
 AH Capital Management LLC Investment ManagersFinance AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01.01.2020 |
Ausbildung von Kouki Harasaki
| Harvard Business School | Graduate Degree |
| University of Cambridge | Graduate Degree |
| Cornell University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
M12 Ventures
M12 Ventures Investment ManagersFinance M12 Ventures (M12) is a venture capital subsidiary of Microsoft Corp. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
Artificial, Inc.
Artificial, Inc. Packaged SoftwareTechnology Services Artificial, Inc. engages in the development of software to close the loop between humans and robots in the lab. It offers flow scheduler, elements SDK, flow tools, and substrate core. The company is headquartered in Palo Alto, CA. | Technology Services |
Huue, Inc.
Huue, Inc. BiotechnologyHealth Technology Huue, Inc. develops biotechnology to provide indigo dyeing solutions to the textile and fashion industry. The company was founded by Michelle Zhu and Tammy Hsu in 2018 and is headquartered in San Francisco, CA. | Health Technology |
Code Ocean, Inc.
Code Ocean, Inc. Packaged SoftwareTechnology Services Code Ocean, Inc. operates as a cloud-based computational reproducibility platform. It provides researchers and developers to share, discover and run code published in academic journals and conferences. The company was founded by Simon Adar in 2015 and is headquartered in New York, NY. | Technology Services |
AH Capital Management LLC
AH Capital Management LLC Investment ManagersFinance AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California. | Finance |
Hanwha Impact Partners, Inc.
Hanwha Impact Partners, Inc. Investment ManagersFinance Hanwha Impact Partners Inc (Hanwha Impact Partners) is a venture capital firm founded in 2022 by Kouki Harasaki. The firm is headquartered in San Francisco, California. | Finance |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Commercial Services |
